Immune aspects of the breast tumor microenvironment

被引：11

作者：

Chawla, Akhil ^{[1
]}

Alatrash, Gheath ^{[2
]}

Wu, Yun ^{[3
]}

Mittendorf, Elizabeth A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA

来源：

BREAST CANCER MANAGEMENT | 2013年 / 2卷 / 03期

关键词：

D O I：

10.2217/BMT.13.15

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The immune response in the tumor microenvironment is complex, consisting of cells from both the adaptive and innate immune systems. The phenotype and function of these cells are dictated by cytokines present in the microenvironment, as well as by the interactions of these cells with the tumor cells and each other. Technological advances have allowed investigators to better identify the specific immune cells present and immune-related gene signatures overexpressed in the tumor microenvironment. Increased knowledge of tumor immunology has allowed us to better understand how these cells and the developing tumor interact. Together, these advances have prompted the conduct of numerous studies investigating the prognostic and predictive significance of immune infiltrates.

引用

页码：231 / 244

页数：14

共 80 条

[11]

CHIN Y, 1992, ANTICANCER RES, V12, P1463

[12] Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].

Clynes, RA ;

Towers, TL ;

Presta, LG ;

Ravetch, JV .

NATURE MEDICINE, 2000, 6 (04) :443-446

[13] Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast [J].

Coronella, JA ;

Spier, C ;

Welch, M ;

Trevor, KT ;

Stopeck, AT ;

Villar, H ;

Hersh, EM .

JOURNAL OF IMMUNOLOGY, 2002, 169 (04) :1829-1836

[14] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].

Curiel, TJ ;

Coukos, G ;

Zou, LH ;

Alvarez, X ;

Cheng, P ;

Mottram, P ;

Evdemon-Hogan, M ;

Conejo-Garcia, JR ;

Zhang, L ;

Burow, M ;

Zhu, Y ;

Wei, S ;

Kryczek, I ;

Daniel, B ;

Gordon, A ;

Myers, L ;

Lackner, A ;

Disis, ML ;

Knutson, KL ;

Chen, LP ;

Zou, WP .

NATURE MEDICINE, 2004, 10 (09) :942-949

[15] Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer [J].

de Jong, R. A. ;

Leffers, N. ;

Boezen, H. M. ;

ten Hoor, K. A. ;

van der Zee, A. G. J. ;

Hollema, H. ;

Nijman, H. W. .

GYNECOLOGIC ONCOLOGY, 2009, 114 (01) :105-110

[16] HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients [J].

de Kruijf, Esther M. ;

Sajet, Anita ;

van Nes, Johanna G. H. ;

Natanov, Russ ;

Putter, Hein ;

Smit, Vincent T. H. B. M. ;

Liefers, Gerrit Jan ;

van den Elsen, Peter J. ;

van de Velde, Cornelis J. H. ;

Kuppen, Peter J. K. .

JOURNAL OF IMMUNOLOGY, 2010, 185 (12) :7452-7459

[17] Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy [J].

DeNardo, David G. ;

Brennan, Donal J. ;

Rexhepaj, Elton ;

Ruffell, Brian ;

Shiao, Stephen L. ;

Madden, Stephen F. ;

Gallagher, William M. ;

Wadhwani, Nikhil ;

Keil, Scott D. ;

Junaid, Sharfaa A. ;

Rugo, Hope S. ;

Hwang, E. Shelley ;

Jirstroem, Karin ;

West, Brian L. ;

Coussens, Lisa M. .

CANCER DISCOVERY, 2011, 1 (01) :54-67

[18] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer [J].

Denkert, Carsten ;

Loibl, Sibylle ;

Noske, Aurelia ;

Roller, Marc ;

Mueller, Berit Maria ;

Komor, Martina ;

Budczies, Jan ;

Darb-Esfahani, Silvia ;

Kronenwett, Ralf ;

Hanusch, Claus ;

von Toerne, Christian ;

Weichert, Wilko ;

Engels, Knut ;

Solbach, Christine ;

Schrader, Iris ;

Dietel, Manfred ;

von Minckwitz, Gunter .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) :105-113

[19] Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes [J].

Desmedt, Christine ;

Haibe-Kains, Benjamin ;

Wirapati, Pratyaksha ;

Buyse, Marc ;

Larsimont, Denis ;

Bontempi, Gianluca ;

Delorenzi, Mauro ;

Piccart, Martine ;

Sotiriou, Christos .

CLINICAL CANCER RESEARCH, 2008, 14 (16) :5158-5165

[20] B Cells Are Required for Optimal CD4+ and CD8+ T Cell Tumor Immunity: Therapeutic B Cell Depletion Enhances B16 Melanoma Growth in Mice [J].

DiLillo, David J. ;

Yanaba, Koichi ;

Tedder, Thomas F. .

JOURNAL OF IMMUNOLOGY, 2010, 184 (07) :4006-4016

← 1 2 3 4 5 6 7 8 →